By Ms Helen Monaghan

Conference Abstracts

Zan J; Wong MG; Kim D; Shi S; Monaghan H; Perkovic V; Lv J; Zhang H, 2025, '#2009 Impact of systemic glucocorticoids on Gd-IgA1 levels in Immunoglobulin A Nephropathy: insights from the TESTING trial', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 40, pp. gfaf116.0437, http://dx.doi.org/10.1093/ndt/gfaf116.0437

Kim D; Woodward M; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Perkovic V; Zhang H; Wong MG, 2025, '#745 Sex differences across treatment response to corticosteroids and kidney outcomes in IgA nephropathy: insights from the TESTING trial', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 40, pp. gfaf116.0351, http://dx.doi.org/10.1093/ndt/gfaf116.0351

Lin FP; McKay S; Zaheed M; Douglas B; Ke H; Koh B; Liang S; Morrow A; Chan J; Chua B; Kennedy E; Leaney K; Monaghan H; Middleton S; Ballinger ML; Thomas DM; Parkinson B; Tucker K; Goldstein D; Taylor N, 2025, '781P Impact of a quaternary genomics multidisciplinary team (MDT) on oncological decision-making: Pilot phase of the UNSW precision care initiative (PCI)', in Annals of Oncology, Elsevier, Vol. 36, pp. s1991 - s1992, http://dx.doi.org/10.1016/j.annonc.2025.10.1195

Canney M; Shan S; Er L; Billot L; Han J; Wong MG; Monaghan H; Cattran DC; Barbour S, 2025, 'Predicting individual patient response to corticosteroids in IgA nephropathy: a secondary analysis from the TESTING cohort', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Vol. 40, http://dx.doi.org/10.1093/ndt/gfaf116.0199

Kim D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Billot L; Zhang H; Perkovic V; Wong MG, 2022, 'EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISONE IN IGA NEPHROPATHY: THE TESTING TRIAL', in NEPHROLOGY, WILEY, Vol. 27, pp. 14 - 14

Back to profile page